Journal article icon

Journal article

Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment.

Abstract:
Acute myeloid leukemia (AML) is the most common acute leukemia in adults and the second most common frequent leukemia of childhood. Patients may present with lymphopenia or pancytopenia at diagnosis. We investigated the mechanisms by which AML causes pancytopenia and suppresses patients' immune response. This study identified for the first time that AML blasts alter the immune microenvironment through enhanced arginine metabolism. Arginase II is expressed and released from AML blasts and is present at high concentrations in the plasma of patients with AML, resulting in suppression of T-cell proliferation. We extended these results by demonstrating an arginase-dependent ability of AML blasts to polarize surrounding monocytes into a suppressive M2-like phenotype in vitro and in engrafted nonobese diabetic-severe combined immunodeficiency mice. In addition, AML blasts can suppress the proliferation and differentiation of murine granulocyte-monocyte progenitors and human CD34(+) progenitors. Finally, the study showed that the immunosuppressive activity of AML blasts can be modulated through small-molecule inhibitors of arginase and inducible nitric oxide synthase, suggesting a novel therapeutic target in AML. The results strongly support the hypothesis that AML creates an immunosuppressive microenvironment that contributes to the pancytopenia observed at diagnosis.
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1182/blood-2013-01-480129

Authors



Journal:
Blood More from this journal
Volume:
122
Issue:
5
Pages:
749-758
Publication date:
2013-08-01
DOI:
EISSN:
1528-0020
ISSN:
0006-4971


Language:
English
Keywords:
Pubs id:
pubs:401461
UUID:
uuid:4cd5c549-f15c-4cbc-8a02-8784ee501101
Local pid:
pubs:401461
Source identifiers:
401461
Deposit date:
2013-11-17

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP